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Studies  concerned with  the natural  antibodies and the complement system 
in  the  serum of nurse sharks included  the  separation of the  first component 
(C'I~) from other complement components and from antibody (1). Hemolytic 
assays for C'I~ activity of crude preparations often exhibited  typical inhibi- 
tion patterns at high C'IN concentrations. Since guinea pig C'4, C'2 and C'3- 
C'9 were used  for the  hemolytic assays of  C'lr~,  the  inhibition  was initially 
believed to be due to the destructive action of C'IN for the fourth and second 
component of the guinea pig complement system. It was soon found, however, 
that  the  magnitude  of the  inhibition  was independent  of the  C'I~ titer  and 
that,  dependent  on  the  isolation  procedure  used,  C'IN  preparations  could 
greatly vary in this respect. These observations led to a  successful attempt to 
separate a material from shark C'IN which specifically inactivated mammalian 
C'4 in vitro and in vivo. This paper deals with the generation, isolation, puri- 
fication,  and  characterization  of  this  C'4 inactivator  and  it  furthermore  in- 
dudes some initial in vivo experiments demonstrating its usefulness as a  com- 
plement blocking agent.' 
Materials and Methods 
Dilu~nts.--The buffers used were either isotonic Veronal buffers containing Ca  ++, 0.00015 
M, Mg  ++, 0.0005 M, and 0.1% gelatin (gelatin-Veroual)  or a mixture of equal parts of gelatin- 
Veronal containing twice the amount of Ca, Mg, and gelatin with 5% glucose in water 0glu- 
cose-gelatin Veronal) (2). When chelating buffers were required, gelatin-Veronal prepared 
without Ca and Mg was mixed with 0.087 u  EDTA  ~ to give final concentrations of 0.04 or 
0.01 M EDTA. Phosphate buffered sodium chloride solutions of various ionic strengths con- 
tained 0.005 K phosphate buffer, pH 7.5 (PBS). 
* Supported in part by Grants 5R01-AI-05758 and  l-R01 A1 08569-01A1, United  States 
Public Health Service, and National Institutes of Health, Bethesda, Maryland, and by Grant 
E-T 381B from the American Cancer Society. 
1  Reported in part at the Third International  Complement Workshop, Harvard Medical 
School, Boston, Massachusetts, June 3-5, 1968. 
2  Reagent grade disodium ethylenediaminetetraacetate  (NazI-I2  EDTA)  was titrated  to 
pH 7.4 with NaOH to give a 0.087 ~ stock solution. 
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Sheep Erythrocytes (E).--Blood from individual sheep was collected in modified Alsever's 
solution (3)  and stored at 4°C.  For each batch, cell counts were correlated with spectropho- 
tometrically measured hemoglobin concentrations. 
" Ra6t~i~ Antibody (A)~S~nsitized  Sheep E~ythrocytes (EA).--Immunoelectrophoretically-pure 
IgG fractions from the serum of rabbits immunized with thoroughly washed, intact sheep E 
were used for optimal sensitization (3). 
Guinea Pig Complement (C'), C!-Components and C'-Fractions.--Pooled guinea pig serum 
was used as a source of C'. The serum was either obtained from our own Hartley strain guinea 
pigs or was purchased from HylSnd Laboratories, Los Angeles, Calif. A serum fraction rich 
in all components except C'I  (sup&nate I)  and purified C'-components were prepared  as 
outlined in reference 2, 
Intermediate Cell Complexes.--The intermediate complexes EAC'I s, EAC'I s4, and EAC'4 
were prepared as outlined in (2); the complex' EAC'I a-7 according to reference 4. 
Nurse shark sera.--The sharks were kept in open pens at the Lerner Marine Laboratories 
(Bimini, Bahama islands). For bleeding, the animals were anesthetized with ethyl-re;amino- 
benzoate methane sulfonic add  (1 g per 4000 ml of sea water). Blood was drawn from the 
hemal arch and was collected individually. The blood was allowed to clot at room temperature, 
was then chilled to 4°C  and centrifuged in the cold. Sera to be used as a  source of natural 
antibody were frozen at -: 75°C. To preserve their complement activity sera were either stored 
at 0°C or after removal of the urea at -75°C  (1, 5). 
Nurse Shark Antibody  (As)=Sensitized Sheep E  (EA•).--Whole  serum from one normal 
nurse shark was used as a source of natural antibody for the sensitization of sheep erythro- 
cytes. EA:~ were prepared by two methods: (a) washed sheep E  in gelatin-Veronal at a con- 
centration of  1  X  109/ml were mixed with equal volumes of heat-inactivated  (30 rain at 
56°C) nurse sharkserum diluted I:10 in gelatin-Verona  L The mixture was first incubated in 
a  shaking water bath for 30 rain at 37°C and then at 0°C for another 30 min. (b) The cells 
were suspended and mixed with the unheated serum diluted in gelatin-Veronal, containing 
0.04 M EDTA, and the mixture was incubated for 1 hr at 30°C.  In both procedures the sensi: 
tized cells were then washed and stored as described for EA. Cells prepared according to these 
two methods wer  e optimally reactive with nurse shark complement but were not lysed by 
guinea pig C! unless C'lt¢ was supplied (1, 5). 
Measurement of C'lz¢ Hemolytic Reactivity)--1  volume of  EA  N  1  X  10S/ml  in gelatin- 
Verona] was incubated with 1 volume of dilutions of C'IN for 20 rain at 30°C, then 2 volumes 
of gelatin-Veronal were added, followed by 1 volume of guinea pig superuate I  diluted 1:8 in 
gelatin-Veronal. The reaction mixture was then incubated at 37°C for 60 min. These assays, 
as all other hemolytic assays mentioned in this paper, were  done either in microtiter plates 
using a total of 5 volumcsof 0.025 ml each, or in tubes with 5 volumes of 0.5 ml. In the latter 
case, 5.0 ml of cold saline were added to each tube at the end of the incubation period, the 
tubes were centrifuged in the cold  and  the :release  of oxyhemogiobin was  measured  spec- 
trophotometrically in the supernatant fluid at  415 m#.  Spontaneous lysls controls, reagent 
controls, and 10~o lysis controls were included in each assay. 
Measuremog  of C'4 Activity in Mammalian  Materials.--1  volume of  dilutions of whole 
serum, C'4 contain~ug serum fractions, or purified C'4 in glucose-gelatin-Veronal was incubated 
with 1 volume of EAC'la 1 X  10S/ml for 20 rain at 30°C. 1 volume of purified C'2, enough to 
supply  75-100 C'HS0 ~nits per cell, was then added  and incubation was continued for 10 
more rain. Finally 2  Volumes of whole complement diluted  1:25  in 0.04 M EDTA-gelatin: 
Veronal (C'-EDTA)  were added  to  the reaction mixture which was  then incubated for 60 
rain at 37°C. 
* A  detailed  description  of  methods  concerning  the  preparation  and  measurement  of 
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Measurement of C'4 tnactivator Activlty.--Depending  on the degree of accuracy and re- 
producibility required, three different hemolytic assay methods were used.  Once it was es- 
tablished  that  C'4 was the only mammalian complement component affected by the inac- 
tivator, a simple and rapid method was designed.  Dilutions of the inactivator were incubated 
for 15 rain at 37°C with a dilution of whole guinea pig complement containing 5 CrHS0 units 
per nil. Then 2 volumes of gelatin-Veronal were added and 1 volume of EA (1 X  10S/ml) and 
incubation was continued for 60 rain at 37°C. The titer of the inactivator was then expressed 
as the highest dilution that inactivated four out of five C'H50 units of whole complement. 
The two other methods, which were based  on measurements of C'4 rather than whole C t 
activity, are described under Results. 
Sucrose Density Grad~nt  U~raventrifugation Analysis.L--The  40%-10% sucrose gradients 
were prepared in 0.15 ~  NaC1 containing 0.005 ~  Trls buffer, pH 7.5. 0.5 ml of the test ma- 
terial was layered over 4.0 ml of the gradient in cellulose nitrate tubes (Beckman No. 305050): 
The tubes were centrifuged in a Spinco Model L ultracentrifuge for 17 hr at 35,000 rpm using 
the type SW 25.1 swinging bucket rotor. At the end of the run, the tubes were punctured and 
fractions were collected from the bottom of the gradient. The number of fractions was usually 
108-115,  each representing 3 drops. The fractions were collected into the wells of microtiter 
plates.  The  peak  reactivities were  determined  by  microtitrations  and  the  corresponding 
S-values were calculated from the position of the reference material  (6.6S rabbit anti-sheep 
E IgG) in comparison with an original calibration run (111 fractions). 
Rabbit Antlsera agalr~t Whole Nurse Shark Serum and Crude Ct4 Inactivator Preparations.--: 
New Zealand white rabbits were immunized over a time period of 3 to 4 months by subcu- 
taneous injections of whole normal nurse shark serum or crude Ct4 inactivator preparations.- 
The latter were obtained by precipitation at 22°C as described under Results and were similar 
to those used as starting materials for further purification by gel filtration. Both antigens 
were homogenized in equal amounts of complete Freund's adjuvant and were administered 
subcutaneously at five sites, each receiving 0.2 ml, representing a total dose of 0.5 ml of un- 
diluted antigen. After three such multiple injections spaced at least 1 month apart, the ani- 
mals were bled.  If desired,  the rabbits  were later boosted by intracutaneous  injections of 
antigen without adjuvant. 
Iramunodectrophoresis.--Microscope  slides  coated  with  2.0  ml  of  1.5%  Noble  agar  in 
Veronal buffer (ionic strength 0.1,  pH 8.6)  were charged with the antigen. Electrophoretie 
separation was achieved in !10 rain under conditions of constant current  (35 to 45 ma, de- 
pending on the number of slides).  The slides were read or photographed 24-48 hr after the 
troughs were charged with antibody. During this time they were kept in moist chambers at 
room temperature. 
Chemicals.--Diisopropyl  fluoro-phoephate (DFP) was obtained from K  & K Laboratories, 
Plainview, New York; Trypsin  (2  X  crystallized) and Trypsin inhibitor (3  X  crystallized, 
from soybean) from Sigma Chemical Co., St. Louis, Mo. 
RESULTS 
Generation of the C'4 Inactivator.-- 
The  C'4 inactivator was first detected  in preparations  of C'IN obtained  by 
low ionic strength  precipitation of normal nurse shark  serum under  conditions 
similar to those described for the isolation of guinea pig C'I  (2).  Neither nor- 
The adaptation of this method  to mierotiter assays for materials that can be measured 
by immune-hemolytic titrations was developed by Dr. Ruth Fugmann in 1965. Unpublished 
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mal whole serum, nor serum from which the urea was previously removed, had 
any detectable inactivator activity. If the ionic strength of the serum, which 
was  normally that  of a  0.25 M NaCI  solution, was lowered  to 0.035-0.04 M 
NaCI by dilution with water at the original pH of 7.5,  a  precipitate formed 
which contained most of the C'l~r activity (95-99%).  The precipitate could 
be washed extensively in the cold with 0.04 ~  PBS without loss of inactivator 
or C'I•.  If the washed precipitate was dissolved in 0.25 ~¢ PBS and centrifuged 
to  remove insoluble material,  the  supernatant fluid contained a  mixture of 
C'IN and the C'4 inactivator. It soon became apparent that the content of 
inactivator in such preparations depended greatly on (a)  the temperature at 
which the initial precipitation was carried out and (b) how the precipitate was 
treated before it was dissolved. 
A.  Precipitation  at  2J°C.  One  volume  (50  ml)  of  freshly obtained  shark 
serum was mixed with six volumes of distilled water and stirred for 30 rain at 
22°C.  The ionic strength of the mixture was that of a 0.036 ~  NaCI solution. 
The precipitate which formed was centrifuged and washed twice in 40 ml of 
0.036 ~  PBS at the same temperature. The final precipitate was then chilled 
to 0°C and dissolved in 10 ml of ice cold PBS 0.25 ~.  1.0 ml portions of the 
dissolved precipitate were then incubated at 30°C for various periods of time, 
mixed with 4.0 ml 0.25 ~t PBS  (0°C)  and centrifuged in the cold. The clear 
supernatant fluid was tested for CtlN and inactivator activity. One portion of 
the dissolved precipitate was diluted 1:5 in cold 0.25 ~  PBS and kept at 0°C 
at all times. 
B.  Predpitation  at O°C. Exactly the same procedure  was followed except 
that the temperature was kept at 0°C at all times and the final precipitate was 
dissolved directly at 0°C (to the original serum volume). 
C.  Prexit~ation at 37°C. Precipitation at 37°C was exactly the same as in B, 
except for the difference in temperature during precipitation. The precipitate 
was washed at room temperature, then chilled, and dissolved at 0°C. 
D.  Precipitation at O°C followed  by incubation  of the suspended  precipitate  at 
different  temperatures. Precipitation was done as in section B  above. The final 
precipitate, however, was not dissolved but suspended in the original volume 
(serum volume) in 0.036 ~t PBS at 0°C. Equal volumes of this suspended pre- 
cipitate were then incubated at 0 °, 30  °, and 37°C for 30 min, then chilled to 
0°C, and centrifuged cold. The supernatant fluids were tested, the sediments 
were dissolved in ice cold 0.25 ~t PBS, centrifuged, and also tested for inacti- 
vator and C'IN activity. 
Table I  contains representative data which were gathered over a  period of 
several  months.  It  summarizes inactivator  and  C'IN  activities  obtained  by 
various precipitation procedures; also listed is the OD~s0 as an indication of 
purity. It is not clear at present by what mechanism the inactivator is formed. 
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generation process is complex and probably involves enzymatic activation  or 
degradation  of  a  precursor.  (a)  If  the  low ionic  strength  precipitation,  the 
washing of the precipitate,  and its  solution  were  performed  strictly at 0°C, 
no  inactivator was  formed. The  low  grade  inactivation  of  C'4  that  disap- 
peared upon heating to 56°C for  2  rain  (see  below)  was  presumably  due  to 
TABLE I 
Generation  of C4 Inactivator under Various Conditions 
ODin of 
Conditions of formation  Inactivator titer  C'IN tlter  inactivator 
D~tions 
(see text)  Unheated  $6* 2 rain  Unheated  56  ° 2 rain  (inigal serum 
volume) 
Precipitation at 2g*C 
ppt. dissolved at 0*C  500  500  6,400  0  1.65 
then incubated  at 30"C 
for 5 rain.  500  500  6,400  0  1.75 
for 15 rain.  500  500  6,400  0  1.69 
for 60 rain.  500  500  6,400  0  1.75 
Precipitation at O°C 
ppt. dissolved at O°C  256  0  6,400  0  3.29 
Precipitation at 37"C 
ppt.  dissolved  at 0°C  500  500  6,400  0  1.65 
Precipitation at O°C 
ppt-suspension  30 rain. at: 
0°C sup.  0  0  20  0  0.29 
ppt.  256  0  5,000  0  2.90 
30°C sup.  0  0  0  0  O. 58 
ppt.  500  500  10,000  0  2.18 
370C sup.  6,000  6,000  0  0  0.75 
ppt.  256  256  40  0  2.50 
the C'I~ content of the material.  (b)  Incubation of the dissolved precipitate, 
no matter at what temperature it was obtained,  did not increase the inacti- 
vator  activity.  (c) The inactivator was formed if the serum was precipitated 
at room temperature or at 37°C. In both cases it was found in the precipitate, 
insoluble even in large volumes of low ionic strength PBS. When the precipi- 
tate  was  dissolved  in 0.25 g  PBS  it  went  into solution  together  with  C'IN, 
from which  it  could be  distinguished  by  its  greater  heat  stability  at  56°C. 
(d) Inactivator preparations with the highest specific activity were obtained if 
the 0°C precipitate was suspended in low ionic strength buffer and incubated 
at  37°C.  Only in this case  the  activity  was found in the  low ionic strength 
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Since  the  last  mentioned  procedure  was  developed  recently,  experiments 
reported  in  this  paper,  unless  otherwise  stated,  were  performed  with  inacti- 
vator  preparations  that  were  obtained  by precipitation  at  0.035~).04 M,  pH 
7.5,  at  room  temperature  (22°C).  The  washed  precipitate  was  dissolved  in 
0.25 ~  PBS, stirred  at 30°C for 1 hr, centrifuged, and stored at 0°C overnight. 
FIG.  1.  (Inactivator column I-l) Pooled normal nurse  shark  serum was precipitated  at 
room temperature  (as described in the text)  and the dissolved precipitate  was concentrated 
by pressure  filtration  through Diaflo membrane  No.  1.* The concentrate,  cleared by cen- 
trifugation,  served as starting material for a 2 X 40 cm Sephadex O-150 column, equilibrated 
with 0.15 ~  PBS. The starting  material  had an ODin of 15.0, a C'I~ titer of 1:12,000, an 
inactivator titer of 1:10,000 and a sheep E agglutination titer of 1:640. 3 ml of this material 
were applied to the column, which was run at room temperature  at a flow rate of 25 ml/hr. 
25 ml of the effluent were discarded before the collection of 3.5 ml fractions was begun. 
During  the  cold  storage,  bulky  precipitates  formed,  which  were  soluble  at 
30°C,  contained up to 25 %  of the total  protein,  and could be removed with- 
out loss  of inactivator  or  C'1~ activity.  Such  preparations  could be  kept  at 
--75°C  or  0°C  for several  months  without  detectable  loss  of  activity;  they 
served as starting materials  for further purification procedures. 
Purifwation of the C'4 Inaztivator.--These crude preparations contained very 
little  whole complement reactivity  but were contaminated  with  10%  to 30% 
of  the  natural  anti-sheep  E  antibody  and,  as  mentioned  earlier,  with  more 
* Amicon Corp., Lexington, Mass. JOERO A.  J~S~N  223 
than 90% d  the total C'IN. Practically all remaining shark complement com- 
ponents (as measured by the reactivity with EA~C'IN) and most of the natural 
antibody  remained  in  the  supernatant  fluid.  Purification  of  the  inactivator 
was therefore primarily concerned with its separation from the known hemo- 
lyticatly active materials,  C'IN and antibody. 
Fro. 2.  (Inactivator column VI-1) Pooled normal nurse shark serum was precipitated as 
before. The precipitate was dissolved in ~  the original serum volume in 0.25 g PBS, chilled 
to 0°C, centrifuged in the cold, and used as starting material for a 5 X 45 cm Sephadex G-100 
column, equilibrated with 0.25 M  PBS. The starting material had an OD~0 of 12.0, a  C'1~ 
titer of 1:100,000, an inactivator titer of 1:10,000, and a sheep E agglutination titer of 1:200. 
25 ml of this material were applied to the column which was run at 4°C with a flow rate of 
90 ml/hr.  100 ml of the efltuent were discarded before the collection of 11.0 ml fractions 
was begun. 
Separation by Gel Filtration.--Figs.  1 and  2  show the behavior d  the  Ct4 
inactivator in its relation to antibody and C'IN on gel filtration using Sepha- 
dex G-150 and G-100 respectively. Both the column profiles show good separa- 
tion of the inactivator from antibody and from C'IN. The yield was usually 
between 50%  and 80%. The specific  activity of the pooled inactivator frac- 
tions was approximately 25 times that of the starting material of the columns. 
All  of  the  applied  C'IN and  antibody was  associated with  the  first protein 480 
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peak.  Some  Ct4  inactivating  activity was  almost  always  found  in  the  high 
Cqs  fractions. About 30% of this activity disappeared on heating and could 
therefore be contributed  to  C'IN. The remainder however,  showed  the  same 
heat  stability as  the  later eluting  C'4 inactivator.  It is not  clear at present 
whether this large molecular material is an aggregation product of the inacti- 
vator or whether it is an unrelated substance with similar properties. 
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Fro. 3.  Sucrose density gradient ultracenttifugation: 10%-40% sucrose gradient; 17 hr at 
35,000 rpm Spinco Model L ultracentrifuge. Reference materials: Rabbit anti-sheep E TgG 
and IgM. [nactivator: preparation II-l: pool from Sephadex (3-150 column, concentrated 4.5 
times, OD~ 1.8, titer  1:3200. Tube i) IgG -t- inactivator  -k buffer; tube ii)  IgM q- inac- 
tivator -i- buffer; tube iii) IgG -t- IgM q- inactivator. After compensating for differences in 
fraction numbers 109, 113, 108 for i, ii, iii, respectively, the  various peak activities were 
found to reside in the same fractions in all three tubes. 
Further  purification  of  the  active fractions  was  possible  by ion  exchange 
chromatography on cellulose columns,  but  the yield was poor.  It was there- 
fore decided to use the functionally pure, but only chemically partially puri- 
fied  preparations  obtained  from Sephadex  columns  for further  characteriza- 
tion of the properties of the inactivator. 
Physico-Chemical  Characteristics.-- 
A.  Estimation  of  molecular  weight:  From  the  known  parameters  of  the 
Sephadex  column  used  in  Fig.  1,  it  was  apparent  that  the  inactivator  was 
retarded more than guinea pig serum albumin and therefore had probably a JOERG A.  JENSEN  225 
smaller molecular weight.  Sucrose gradient ultracentrifugation supported this 
assumption. 
Fig. 3  is a  composite graph of the sedimentation characteristics of the C'4 
inactivator and rabbit anti-sheep E  IgM, and IgG. The calculated S-value for 
the  inactivator  was  3.3S  based  on  comparison  with  6.6S  Rabbit  IgG.  C'IN 
(not shown)  sedimented with the rabbit IgM. 
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FxG. 4.  Effect of heat treatment on the C'4 inactivator and on C'1~ ; effect of trypsin 
treatment on inactivator; a series of tubes containing 0.5 ml of C'4 inactivator (IT-l, tlter 
1:6400)  of whole shark serum  (C'IN titer 1:12,000)  or purified  C'IN (titer 1:6.400)  were 
prewarmed to 37°C and placed in a 56°C waterbath at zero time. At the indicated times, du- 
plicate tubes were removed from the bath, chilled, and the residual activity assayed. 
The same inactivator preparation was diluted 1:25 in 0.15 ~ PBS pH 7.5, One ml samples 
were mixed with 0.5 ml of the same buffer containing 0.5 mg trypsin per ml and incubated 
at 30°C for the indicated periods of time, then 0.5 ml of an adequate concentration of soy 
bean trypsin inhibitor* was added to each tube and the residual activity was assayed and 
compared with a control tube that received PBS instead of trypsin. 
B.  Inactivalion  by heat (56°C) ar~t trypsin:  Fig. 4  shows  the differences in 
heat sensitivity of the inactivator and of C'IN, and the effect of trypsin on the 
inacdvator. 
C. Influence of ptI, dilution, and freezing on stability of the ino~tivator: The 
inactivator was stable at 0°C, room temperature, and at 30°C in the pH range 
* Soy bean trypsin inhibitor has no effect on the C'4 inactivator. 226  INACTIVATOR  OF  MAMMALIAN C'4  FROM  SHARK  SERUM 
of pH 5.0-10.0, whether it was submitted to these conditions in concentrated 
form or at high dilutions without the addition of protective proteins. Incuba- 
tion for 30 min at 30°C at pH 2.0 or pH 3.0 resulted in 75 % loss of activity, 
at pH  11.0 in more than 90%. Repeated freezing and thawing at --20°C  or 
--75°C did not affect neutral dilute or concentrated inactivator preparations. 
The Anticomplementary Activity of the C'4 Inactivator and its Specificity.-- 
A.  In  vitro:  As mentioned above,  the anticomplementary activity of low 
ionic strength precipitates obtained from nurse shark sera was first observed 
when these materials were tested for C'IN hemolytic reactivity. In these tests 
EA~ were incubated with dilutions of the dissolved precipitate for 30 min at 
30  ° to form EAN C'IN which were then brought to lysis with guinea pig super- 
nate I  or whole guinea pig C' in a  dilution of 1:8 or 1:25  respectively. The 
degree of lysis was proportional to the concentration of the crude C~I~ prepa- 
rations  except  in  some  instances,  where high concentrations showed strong 
inhibition of the lytic reaction. This inhibition could be dramatically increased 
if the guinea pig C ~ or supernate I was preincubated with the precipitate dilu- 
tions before the cells were added. This indicated that the anticomplementary 
action was  directed  against  the  guinea pig  complement components  rather 
than against the cells or C'I~. Since it was not clear at this time whether the 
anticomplementary activity was due to the shark C~I~ or to a  different ma- 
terial  contained in  the  precipitate,  fractionation of  the  precipitate  was  at- 
tempted. The partially purified inactivator that resulted from these attempts 
(see above) was completely free of Cq~, shark natural antibody, and to our 
present knowledge, other shark complement components. 
In  order  to  determine which  guinea pig  component or  components  were 
affected by such functionally pure preparations,  the lowest inactivator con- 
centration was chosen, that, if diluted 1:10 in whole guinea pig serum, com- 
pletely inhibited its hemolytic activity after incubation at 37°C for 20 rain. 
Intermediate cell complexes were then treated with that inactivator concen- 
tration  and,  after  washing,  tested  for  their  reactivity in  comparison  with 
control cells which were incubated without the inactivator. Neither optimally 
sensitized sheep erythrocytes, nor EAC~la, EACtla4, EACt4, or EAC'I-7 were 
detectably affected in their sensitivity by this treatment. When the treated 
guinea pig serum was analyzed in terms of residual component activity, it was 
found that no C'4 hemolytic reactivity was detectable. C'I, C'2, C'5, C~8, and 
C'9  which  were  measured  hemolytically and  C'3  as  measured  by  immune 
adherence were unaffected. Since C'6 and C'7 could not be tested individually, 
C'-EDTA was made with the inactivator treated and the untreated control 
serum and both were titrated with EAC'Io4 and constant amounts of C'2 and 
with EACq~42~.  Both C'-EDTA titers were similar. These results allowed the 
conclusion that  the  inactivator was  specifically directed  against  the  fourth J'OERG A.  ~ENSEN  227 
component of the guinea pig complement system. Since highly purified guinea 
pig C'4 was at least as susceptible to the inactivator as C'4 in whole serum, it 
was apparent that no cofactor was required for the inactivation. 
In a similar manner, using the same intermediate cell complexes and guinea 
pig complement components,  the inactivator's anticomplementary action for 
human and dog serum were also found to be due to its specific inactivation of 
C'4. 
B. In dvo:  If inactivator concentrations equivalent to those used in vitro 
were injected intravenously into dogs or guinea pigs, no apparent reaction was 
observed  in the animals.  Within S to  15  rain after the injection,  no whole 
serum  complement  activity was  detectable.  Again  the  anticomplementary 
effect was solely due to the inactivation of the fourth complement component. 
Measurement of C'4 Inactivator Reactivity.-- 
A. By residual C4 titration: When it was established  that the inactivator 
was specifically directed against the fourth complement component and that 
no other serum constituents were required for its action, an assay system was 
developed  which was based  on measurements of residual  C'4 activity rather 
than of residual whole complement activity of inactivator treated material. 
Initial experiments in which purified C'4 was incubated with dilutions of the 
inactivator and then titrated using EACq,, purified C'2, and C'-EDTA showed 
that reproducible  titers could be obtained. However,  inactivation of C'4 pro- 
ceeded very rapidly and the inactivator titers were extremely high if limited 
mounts of C'4 were used in the assay (see below). Rather than using large 
amounts of purified components,  a standard assay was developed using guinea 
pig supemate I  as a source of C'4 and C'2. One volume inactivator dilutions 
in glucose-gelatin-Veronal was mixed with one volume of a  1:25  dilution of 
supernate I in the same buffer. The mixture was incubated for 20 min at 37°C; 
then one volume of EAC'I, (1  ×  l0  s cells per ml in glucose-gelatin-Veronal) 
was added and incubation continued for 20 rain at 30°C. Finally, two volumes 
of C'-EDTA 1: 25 were added, followed by incubation for 60 rain at 37°C. The 
assays were either performed in microtiter plates or in tubes. The concentra- 
tion of supernate I  contained approximately 200 C'HS0 units of C'4 per mi 
and 125 units of C'2. Since addition of purified  C'2 did not alter the results, 
this step was omitted. The filter of the inactivator was expressed as that dilu- 
tion which inactivated all but one of the available  CtH50 units of C'4. The 
time allowed for the inactivation at 37°C was  derived from several  kinetic 
experiments, of which Fig. 5 is an example. It should be kept in mind, however, 
that the actual time during which the inactivation of C'4 occurred in this kind 
of assay was the preincubation time, plus an undefined time interval during 
which inactivation still proceeded while SACqo4 were formed. 228  INACTIVATOR  OF  MAMMALIAN CI4  FROM  SHARK  SERUM 
The  data illustrated in  Fig.  6  were obtained using a  modification of the 
above assay method. In order to decrease the number of variables involving 
temperature changes and changes of reaction mixture volumes, the following 
two step procedure was used. To 0.5 ml of prewarmed (37°C) inactivator dilu- 
tions  (inactivator VL1  pool  5  X  concentrated)  0.5  ml  of also  prewarmed 
supernate I  (1:25)  were added at timed intervals. Without interrupting the 
incubation in the waterbath shaker  1.5 ml of 0.333  X  10S/ml EAC~I~ were 
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FIG. 5. Inactivation of C'4 hemolytic  reactivity of guinea pig supemate I. Constant C'4 
inactivator concentration, variable time of inactivation at 37°C. See text for assay procedure. 
pipetted  into each  tube and incubation was  continued for 60 min at 37°C. 
Finally 5.0 ml of ice cold EDTA-NaC1 were added, the tubes were immedi- 
ately centrifuged, and the optical density of the supernatant fluid was recorded 
at 415 m~. Tubes containing no inactivator showed 100 % lysis, those contain- 
ing inactivator, but no supernate I  showed the same low degree of lysis as the 
spontaneous lysis controls. 
Fig. 5 shows that, after an apparent initial lag period, the inactivation of 
C'4 proceeded rapidly, then slowing down and approaching a plateau at about 
20 min. 
The kinetic data plotted in Fig. 6 demonstrate that the lag periods decreased 
with increasing inactivator concentrations and that the time required for the 
inactivation of all but one CtH50 unit of C'4 (50% lysis) was roughly propor- 
tional to the inactivator concentrations, This relationship was also expressed 
by the velocity of C'4 inactivation between 80% and 60% lysis. JO~-RG A. JENSEN  229 
Since we are  at present unable to stop the inactivator action at a  given 
moment, it was not possible, using these assay methods, to really titrate resid- 
ual C'4. What was actually measured was the activity of the last few C~HS0 
units of C'4 that remained hemolytically active after at least 190 units were 
inactivated. This accounts for the longer lag periods at low inactivator concen- 
trations. The early plateauing that can be seen in Fig. 5 and 6 and the slow 
approach  to  100%  inhibition  or  0%  lysis respectively,  could have  various 
reasons--among  them,  the  possible  presence  of inhibitory substances in the 
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FIG. 6.  Inactivation of C~4 hemolytic reactivity of guinea pig supernate  I. Two-fold Ct4 
inactivator dilutions; variable time of inactivation  at 37°C. See text for assay procedure. 
guinea pig supernate I, and the highly efficient lytic system in the absence Of 
EDTA (Fig. 6). In order to avoid both these difficulties, similar kinetic experi- 
ments with limited amounts of purified  C~4 were performed  (Fig.  7).  Four 
concentrations  of  a  purified  C~4-inactivator  preparation  were  incubated  at 
37°C with 10 and 15 C~HS0 units of purified C'4. After the given time intervals 
EAC~I~ were added to each tube, followed by Ct2 and Ct-EDTA as in a stand- 
ard  C~4 assay. For each preincubation time, the degree of inhibition, when 
plotted against the dilutions of the inactivator, described a  curve which was 
concave to the dose scale. In Fig. 7 this relationship was converted to one of 
direct proportionality by plotting arithmetically the negative natural logarithm 
of the lysed cells, i.e., --In (1- % inhibition) against the dilutions of the inac- 
tivator. 
It is apparent from Fig. 7 that this type of assay is strongly influenced by 230  INACTIVATOR OF MAMMALIAN C4 FROM SHARK SERUM 
the  time of inactivation and  also by small differences in  C'4 concentrations. 
On  the  other  hand,  if these  two variables were kept  constant,  straight  line 
plots over a  wide range of inactivator concentrations were obtained, provided 
that no large excess of C'4 was used.  With still smaller amounts of C'4  (less 
than  10 units),  inactivation was so rapid that impractically high dilutions  of 
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RELATIVE  INACTIVATOR  CONCENTRATION 
FxG. 7. Inactivation  of purified guinea pig C'4 by two-fold C'4 inactivator dilutions. 10 
and 15 C'H50 units of C'4 were incubated with the inactivator for 2.5, 5, and 10 rain. See 
text for assay procedure. 
the inactivator had to be used in order to obtain a measurable degree of lysis. 
B. Hydrolysis of TAME  5 by the C'4 inactivator: Preliminary experiments indi- 
cated  that  addition  of purified  C'4 inactivator to a  weakly buffered TAME 
solution resulted in a  linear decrease of pH values with  time. To 1.0  ml of a 
0.05 ~  solution of TAME in 0.15 ~  PBS were added 0.15 ml of various inacti- 
vator concentrations at zero time and 22°C. The pH was recorded in the con- 
stantly  stirred  mixture.  Initial  velocities  could  be  easily and  quite  reliably 
obtained  by  this  simple method.  For  example,  a  preparation  of inactivator 
TAME, p-toluene sulfonyl-T.-arginine  methyl  ester hydrochloride. A grade Calbiochem, 
Los Angeles, Calif. JOERG A.  JENSEN  231 
VI-1  (5  X  concentrated) lowered the pH in a  linear fashion from pH 7.57 to 
pH  7.4  in  10 min  under  these  conditions.  Initial velocities were  found to be 
proportional to the concentrations of the inactivator. Samples from two puri- 
fied  inactivator  pools  (VII-l)  were  kindly  tested  by Dr.  Robert  Stroud  for 
FIG. 8.  Immunoelectrophoresis of purified human C'4 (a), and human serum (b). Upper 
wells: treated with C'4 inactivator; lower wells: untreated controls. The troughs contained 
rabbit anti-human C~4. The anode is to the left. 
their  TAME-esterase  activity  by  a  newly  developed  spectrophotometric 
method (6).  The samples which had an OD280 of 0.04 were comparable in their 
activity with  a  purified  human  Cq-esterase  preparation  of an  OD280 of 0.1. 
Their different initial  velocities reflected their  different titers  in terms of C'4 
inactivation. 
The Mechanism of C4 Inactivalion.--Several  observations seem to indicate 
that the inactivation of Ct4 by the Ct4 inactivator is enzymatic. This view is 232  INACTIVATOR  OF  MAMMALIAN  Ct4  FROM  SHARK  SERUM 
supported by the velocity studies with C'4 as substrate and by the preliminary 
experiments with TAME. In addition, the inactivation of C'4 was found to be 
strongly temperature dependent.  For example,  a  given inactivator concentra- 
tion  preincubated  with  CI4  for  20  rain  at  0°C  caused  35%  inhibition  (in  a 
standard  titration),  as compared with  90% if the temperature was 37°C.  For 
a  l0 X  lower concentration of the inactivator under otherwise identical condi- 
tions  the  values  were: less  than  1%  and  60%  respectively.  Furthermore,  it 
was found that the inactivator could be inhibited  by DFP  (see under discus- 
sion). 
In an attempt to demonstrate directly an alteration of the C'4 molecule as a 
result  of inactivator  treatment,  an  immunoelectrophoretic analysis  of highly 
purified  human  C'4  ~ before  and  after  inactivation  was  undertaken.  Fig.  8a 
shows  the  results.  The  treated  C'4 formed  a  foreshortened  precipitation  arc 
with  rabbit  anti-C'46 and  an  anodic shift indicating faster anodic movement. 
Surprisingly, no such change could be detected if normal whole human serum 
was treated and analyzed in a similar manner Fig. 8b. In both cases no residual 
hemolytic C'4 activity was detectable after treatment with  the inactivator. 
Though most of the experimental data seem to favor an enzymatic destruc- 
tion of C'4 as cause for its inactivation an  alternate  explanation,  namely the 
formation of an inactivator-C~4 complex,  can  not be  completely ruled  out at 
the present time. 
Immunoelectrophoresis  of  the  C'4  Inaclivator  (Fig. 9).--Peak  inactivator 
fractions from a  Sephadex  G-100  column  (VII-l) were pooled,  concentrated, 
and analyzed by immunoelectrophoresis in  comparison with  the starting ma- 
terials  of the column and with  whole serum.  The antibody preparations  that 
were used were sera from rabbits immunized (a)  with crude inactivator, con- 
taining as known contaminants, C~IN and natural antibody and (b) with whole 
nurse  shark  serum  (see  Materials  and  Methods).  At  present,  we  interpret 
these findings (Fig. 9)  to mean (i)  that whole serum and also  the crude inacti- 
vator preparations contain a precursor of the C'4 inactivator, (ii) that the par- 
tially purified inactivator is contaminated with the precursor which is precipi- 
tated by both antisera (3a,b) ; (iii) that during inactivator generation, the pre- 
cursor is partially cleaved in two antigenically new fragments, of which one is 
slower,  the  other faster moving than  the  precursor,  and  (iv)  that  the  slower 
moving material  (2b, 3a)  is the inactivator. At the moment, this is a  working 
hypothesis which requires for its verification the isolation of the precursor and 
of the enzyme by which it is cleaved. 
The C'4 In,  activator as Anticomplementary Agent In  Vivo.--The inactivator's 
unique  specificity against  only one  complement component and  its  apparent 
The human Ct4 preparation and the corresponding rabbit antibody was kindly provided 
by Dr. Hans Mtiller-Eberhard. FIG. 9.  Immunoelectrophoresis of partially purified C'4 inactivator and whole nurse shark 
serum.  In Fig. 9  (1)  and  (2)  the upper antigens (a)  were whole shark  serum; the lower  (b) 
partially purified inactivator (peak fractions from G-100, 10  )<  concentrated). The antiserum 
for (1) was anti whole shark serum for (2)  anti crude inactivator. Two distinct precipitation 
arcs can be seen in Fig. 9  (2b), but only one in  (lb). The latter corresponds with the more 
anodic one of the two former ones. 
This relationship is more obvious in Fig. 9  (3), where the antigen was the inactivator and 
the two antisera were compared. In Fig. 9  (4)  the antigen was the crude inactivator, in the 
upper trough was the homologous antiserum  (a),  in  the lower, anti whole shark serum  (b). 
Fig. 9  (4a) shows two arcs that correspond to those formed by the purified inactivator with the 
same antiserum, in addition several others that also appear in (4b). A comparison of (4a) and 
(4b)  reveals however, that  there are two arcs that  are formed with the anti inactivator and 
not with the anti whole shark serum. One is the slower moving of (2b)  or (3a), the other is a 
very fast moving new arc. The anode is to the left. 
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lack  of toxicity for biological  systems at  high,  fully  effective  concentrations 
prompted  various  investigations  concerned  mainly with  the  participation  of 
the  complement  system  in  immune  and  immune-pathological  situations. 
Though most of the results are preliminary and were in part obtained in col- 
laboration with other laboratories, it was decided to briefly discuss them here 
in order to demonstrate the usefulness of an anticomplementary agent with the 
characteristics  of the  C'4  inactivator.  Detailed  reports will  follow at  a  later 
date. 
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t;IG.  10.  Protection of guinea pigs against Forssman shock by a  single intravenous injec- 
tion of the C'4 inactivator. Effect of the inactivator on C' and C' components in vivo. See 
text for details. 
A.  Prevention  of  Forssman  shock  by  treatment  with  the  C'4  inactivator: 
Guinea pigs weighing 500-600  g  were injected  intracardially with  the inacti- 
vator at  a  concentration  that  was estimated  to reduce  the  C~4 activity to a 
titer of less than  1 : 10. At various time intervals,  the animals were challenged 
with  intravenous  injections  of  rabbit  anti-sheep  E  serum  in  amounts  that 
caused lethal shock within 3 min in control animals. Several inactivator treated 
animals were  not  shocked  but  bled  at  various  time intervals  and  the  serum 
titers of whole C', C'I, C'4, C'2, and C'5 were measured. Fig.  10 is a summary 
of these experiments. It can be seen that one injection of inactivator protected 
the animals from 5 min until  135 min after the injection  (longer time intervals JOERG A.  J~NSV.~  235 
were  not  tested).  Challenge  simultaneously with  the  treatment  resulted  in 
death. During the time of observation, the serum levels of C'I, C'2, and C'5 
did not change; the whole complement titer however dropped to 1:2 from its 
pretreatment level of l:S00, stayed low until 30 rain postinjection, and climbed 
then rapidly to almost normal titers, while the animals were still fully protected. 
The rapid normalization of the whole complement reactivity was quite puzzling 
at first and raised the question of a possible in vivo reactivation of the comple- 
ment system, which we had never observed in vitro. All attempts to reactivate 
serum treated in vitro or in vivo by incubation with various minced guinea 
pig  tissues failed.  However, measurements  of  C'4  activity in  the  serum  of 
inactivator-treated  animals  explained  our findings.  Hemolytic C'4 was dra- 
matically lowered by the treatment and recovered very slowly, reaching  2 % of 
its initial value at 50 rain and only 4 % at 90 rain.  But since these 4 % repre- 
sented 800 C'H50 units of C'4 and since no other components of the comple- 
ment system were affected by the inactivator, it was no longer surprising that 
the whole complement activity was almost normal  at this  time.  This situa- 
tion illustrates rather convincingly how misleading estimations of the reactiv- 
ity of the complement system can be if one relies on hemolytic measurements 
of whole complement only. Highly significant  depletion  or destruction  of a 
single  complement  component  (more  than  95%  in  our  case) may have  an 
insignificant  effect on the whole complement titer. 
Arthus reaction: Initial experiments indicated,  as expected, that direct and 
reversed passive Arthus reactions could be suppressed if the C'4 reactivity was 
kept low for an extended period of time. 
B. Passive cutaneous anaphylaxis (PCA): Under none of various experimen- 
tal  conditions was it possible to influence  the PCA  reaction  in  guinea pigs 
using  rabbit  anti-BSA  and  BSA. Whether the animals were treated so that 
C'4 levels were undetectable during the whole experimental period, whether 
the inactivator  was in  addition injected locally with  the antibody or intra- 
venously with the antigen,  no suppression of the PCA reaction could be ob- 
served. 
C. Prolongation  of xenograft rejection times: The rejection of pig kidneys by 
dogs, normally occurring within  10 rain  after anastomosis, was dramatically 
delayed when the dog was treated with one intravenous injection of C'4 inac- 
tivator prior to grafting. The prolongation was of the same magnitude as that 
obtained by in vivo absorption of the dog's natural anti-pig antibodies (7) or 
by treatment with the anticomplementary cobra venom factor (8). 
The C'4 Inactivator  and the Formation  of Biologically  Reactive Materials in 
Guinea Pig Serum.--The inactivator itself did not increase the capillary per- 
meability in the guinea pig skin,  nor did it cause contractions of the terminal 
guinea pig ileum.  Guinea pig serum treated in vitro with the inactivator  to 
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bility at a dilution of 1: 2 and none at a dilution of 1: 20. The serum so treated 
exhibited no smooth muscle contracting activity. Treatment of the inactivated 
serum  with cobra venom factor resulted in the formation of anaphylatoxin; 
there  was  no  apparent  difference between  the  inactivator-treated  and  the 
untreated control serum (9). However, in contrast to normal serum, anaphyla- 
toxin could not be generated in the C~4 deficient serum if it was treated with 
immune precipitates. In collaboration with Dr.  Snyderman and in confirma- 
tion of our former findings (10), it was found that the same relationship holds 
true for the generation of a chemotactic factor generated in guinea pig serum 
upon incubation with endotoxic lipopolysaccharide (LPS). Whereas the chemo- 
tactic factor could be generated in inactivator-treated serum with cobra venom 
factor, its generation with LPS was not possible unless C~4 was added to the 
serum. Relatively small amounts of either residual C~4 in insuflSciently treated 
serum or of purified C~4 added to completely deficient serum was enough to 
allow the formation of the chemotactic factor.  7 
In Vitro Synthesis of C'4 by Guinea Pig Liver (11).--The complete depletion 
of C~4  in  the  tissues  of inactivator treated  guinea pigs made  it  possible  to 
observe the synthesis of Ct4 in minced organ cultures of such animals. All un- 
treated cultures of spleen and liver showed decreasing titers of C~4 and C'2 in 
the culture fluid due to leakage from the  tissues.  However, the inactivator- 
treated cultures contained no detectable C'4 initially but showed comparable 
C'2 titers. Subsequently, C'4 titers increased from 20-40 hr to peak titers of 
1:48 in all treated liver cultures, (not in the spleen cultures) except those con- 
taining puromycin. It was estimated that the guinea pig liver could synthesize 
all serum C~4 in 24-48 hr.  s 
DISCUSSION 
In recent years three specific inhibitors or inactivators of single complement 
components have been isolated from various mammalian sera. The C'I inacti- 
vator from human serum  (12-14) and from guinea pig and rabbit serum are 
known to destroy C'la in the fluid phase and the Cq site of EACqa and EAC  ~- 
la4. The C'3 and C'6 inactivators which have been found in normal human, 
rabbit, and guinea pig sera have no known effect on the corresponding com- 
ponents in the fluid phase but specifically destroy the hemolytic activity and 
in the case of the C'3 inactivator, also the immune adherence reactivity of the 
respective active sites (15). It has been suggested that the existence of specific 
inactivators of complement components in normal serum may constitute an 
important control mechanism for the complement system (15). 
The C'4 inactivator described in this paper apparently has no such function. 
Snyderman, R., J. A. Jensen, and H. Gewiirz.  In preparation. 
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No effect on the complement activity of the shark serum could be observed 
even at inactivator concentrations which rapidly and completely inactivated 
manunalian C'4 in whole serum and highly purified preparation of C'4.  Fur- 
thermore, in contrast to the known inactivators, ours is directed exclusively 
against fluid phase C'4, has no effect on the EACq,4 site, and is not detectable 
in whole serum. The conditions for its generation in low ionic strength precipi- 
tates, seem to indicate that a  precursor might be enzymatically transformed 
to yield a  material with new properties. The mechanism of its generation re- 
quires further investigation. 
TABLE II 
Characteristics  C'4 inactivator  C't-esterase 
Inactivation of C'4 
at 37°C  Rapid  Rapid 
at 0°C  Slow  Rapid (>37°C) (18) 
Inactivation of C'2  No  Yes  (18) 
Inactivation of C'4 in vivo  Rapid  ? 
S-value  3.3  3.7  (19) 
Half life at 56°C  5 rain  30 rain  (18) 
Stability at pH 5.0  Stable  Unstable  (18) 
Hydrolysis of TAME  Yes  Yes 
Inhibited by DFP  Yes*  Yes 
*Ass-mlng a  molecular weight of 40,000 to 60,000 for the C'4 inactivator  and an ap- 
proximate mole per mole inhibition of esterases by DFP, our purest preparation should have 
been completely  inhibited by 10-' ~ DFP. However,  the concentration required for 50% inhi- 
bition was found to be 1000 times greater. 
Recently Opferkuch, Ringelmann  and Klein reported on a  C'4 inactivator 
which was generated in guinea pig euglobulin fractions under essentially simi- 
lar conditions (17). Their material which hydrolyzed TAME also specifically 
inactivated C'4 in the fluid phase, but not C'2. These investigators searched 
for a relationship between their C'4 inactivator and guinea pig C'1. Their data 
were not compatible with the view that  C'1,  acted as a  precursor and that 
their C'4 inactivator could therefore be C'1 esterase.  9 A complete comparison 
of the two inactivators has to wait for a more detailed report from the authors. 
The possible relationship of our inactivator to C'1 esterase as described in the 
human system requires some discussion. There are certain similarities but also 
striking dissimilarities. Table II compares our data with those published for 
human C'1 esterase. 
Obviously, shark C'I esterase neednot be similar in every respect to human 
C'I esterase, but even with this reservation in mind, the following observations 
o  Klein, P. G. Personal communication. 238  INACTIVATOR  Ol  • MAMMALIAN  C'4 FROM  SHARK  SERU~ 
seem incompatible with the assumption that the C'4 inactivator could really 
be shark C'1 esterase: (a) The inactivator could be generated and then sepa- 
rated from Ctl~ without loss of C'1~ activity. (b) The generation of the inac- 
tivator was inhibited rather than enhanced in the presence of EDTA.  (c) In 
spite of the fact that  CtlN like guinea pig C'l, activated guinea pig C'4 and 
Ct2, the C'4 inactivator did not inactivate C'2. Even concentrations that com- 
pletely inactivated  l(Y  8 effective molecules  of C'4 in  a  few minutes had  no 
detectable effect on the hemolytic activity of C'2. These findings  do not abso- 
lutely exclude the possibility that the inactivator could be associated with the 
first component of the shark complement system. Further research concerning 
this  possibility had  to wait for preparations  of highly  purified  C'1~  and  is 
being conducted at the present time. 
Rather than adding it to the list of the above mentioned component inacti- 
vators it seems to be more logical to classify our C'4 inactivator together with 
other  anticomplementary  materials  found  in  nonmammalian  biological  sys- 
tems. 
If compared with the most thoroughly investigated member of this group, 
the cobra venom factor (20, 21), the uniqueness of the C'4 inactivator becomes 
apparent.  While the former is relatively nonspecific,  affects C'3,  C'5, and in 
high  concentrations,  C'6-C'9  (22), 1° is toxic due to the in vivo generation  of 
anaphylatoxin,  and does not inactivate purified  complement components be- 
cause of its cofactor requirement (22), 1° the latter is highly specific, nontoxic, 
and independent of other serum constituents. 
So far we have not found a  specific blocking agent for the C'4 inactivator 
which would allow precise kinetic studies under various conditions with C'4 as 
"substrate."  At  relatively  high  concentrations,  the  initial  velocity  of  C'4 
inactivation seems to be proportional to the concentration of the inactivator. 
Proportionality was also observed between initial velocities of TAME hydroly- 
sis and inactivator  concentrations.  Based on the temperature  dependence of 
inactivation,  the protein nature of the inactivator,  and its effect on the elec- 
trophoretic mobility of human C'4, we are inclined to believe that it enzymically 
destroys C'4. Furthermore,  recent experiments indicate (a)  that  depletion of 
the inactivator is much slower than one would expect if C'4 were inactivated 
by complex formation  and  (b)  that  a  fragment  of C'4 is  formed during  its 
inactivation.  Whether the hydrolysis of TAME is an expression  of the same 
enzymatic activity however, is not beyond question. 
As we learn more about the mode of action of the C'4 inactivator we are 
bound to learn more about Ct4; and as we attempt to elucidate its generation 
and identify its precursor we must be aware of its possible relation to Ctl. If 
C'1 esterase and the C'4 inactivators from shark or guinea  pig serum are two 
independently different substances, then,  considering  their  generation  under 
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identical  conditions in euglobulin fractions,  they are most certainly mutually 
cross-contaminated--at least initially--during preparatory procedures. If they 
are both derived from the C'1 macromolecule, one must find a  basis for their 
dissimilarities  and define their functions. 
Independent of these still  unanswered  questions,  the shark  C'4 inactivator 
has  proven  to be a  valuable  tool in vitro  as well  as in vivo to interrupt  the 
complement system's sequential action by destroying an early link in the chain 
without affecting later ones. Its properties as a specific, efficient nontoxic, anti- 
complementary agent will be helpful in further elucidating the function of the 
complement system and its participation in immune pathological syndromes. 
SU-MMARY 
A material which specifically  inactivates  mammalian C'4 was isolated  from 
low ionic  strength precipitates  of nurse shark serum. The C'4 inactivator  was 
not detected in whole serum. The conditions  of  its  generation and its  immuno- 
clectrophorctic behavior seem to indicate  that it is an cnzymatically formed 
cleavage product of a precursor contained in whole shark serum. The inacti- 
vator was partially  purified  and characterized.  It  had an S-value of  3.3 (sucrose 
gradient) which was in agreement with its retardation on gel filtration,  was 
stable between pH 5.0 and I0.0,  had a half-life  of  5 rain  at 56°C, pH 7.5,  was 
inactivated by trypsin and was nontoxic. Its powerful  anticomplementary 
activity  in vitro  and in vivo was solely  due to the rapid inactivation  of C'4; 
no other complement components were affected.  No cofactor  requirement was 
observed  for the equally rapid inactivation of highly purified human  and 
guinea pig Ct4. The kinetics  of Ct4 inactivation  and TAME  hydrolysis,  the 
greater anodic mobility of inactivated  human C'4, and the influence  of tem- 
perature on the rate  of inactivation  suggest that the inactivator  is an enzyme 
and C~4 its  substrate.  This conclusion  was supported by the more recent  detec- 
tion  of  a split  product of C'4.  Intravenous administration  of the C~4 inactivator 
could  prevent lethal  Forssman shock and suppress the  Arthus reaction  in  guinea 
pigs;  it prolonged significantly  the rejection  time of renal  xenografts but had 
no detectable effect  on passive cutaneous anaphylaxis. Anaphylatoxin could 
be generated in C~4 depleted guinea pig serum with the cobra venom factor, 
but not with immune  precipitates.  The possible relationship  between  Cq 
csterasc and the C'4 inactivator  is discussed on the basis of similarities  and 
dissimilarities. 
I wish to thank Dr. M. Michael Sigel, who was instrumental  in initiating  my interest  in 
the shark's complement system. He and his staff at Variety Children's Research Foundation 
provided  the facilities and the materials  without which this  investigation  would not have 
been possible. The methods for the isolation, purification, and measurement of the first com- 
ponent of shark complement was developed in collaboration with Gordon D. Ross, a gradu- 
ate student of the Department of Microbiology. The technical assistance of Elena Iglesias 
throughout this study has been invaluable. The technical assistance of Kathleen Travino and 240  INACTIVATOR  OF  MAMMALIAN  Ct4  FROM  SHARK  SERUM 
Kate Bressler during the early phases of this study and of Dennis McRae in recent months 
is gratefully acknowledged. 
BIBLIOGRAPHY 
1.  Jensen, J. A., M. M.  Sigel,  and  G.  D.  Ross.  1968. Natural antibody (AN)  and 
complement (C'~) of the nurse shark. Fed. Proc. 27:491. 
2.  Nelson,  R.  A., J.  A. Jensen,  I.  Gigli,  and  N.  Tamura.  1966.  Methods  for the 
separation,  purification  and  measurement  of nine  components  of  hemolytic 
complement in guinea pig serum. Immunochemistry.  3:111. 
3.  Mayer,  M.  M.  1961. In  Kabat  and  Mayer's Experimental  Immunochemistry. 
Charles C Thomas. Springfield,  Ill. 2nd edition. 
4.  Rommel, F. A., and R.  Stolfi,  1968. Preparation and partial  characterization of 
the sheep erythrocyte-antibody-complement intermediate  EAC'la,4,2a, 3,5, 
6,7. Immunology.  15.'469. 
5.  Jensen, J. A., M. M. Sigel, and G. D. Ross. 1968. Some characteristics of natural 
antibody,  complement,  and  a  C'4  inactivator  from  nurse  shark  serum.  J. 
Immunol. 101:816. 
6.  Nagaki, K., and R. M. Stroud.  1969. The relationship  of the hemolytic activity 
of active  C'ls  to its TAME esterase  activity.  A  new method of purification 
and assay. J. Immunol. 102:421. 
7.  Linn, B.  S.,  J.  A. Jensen,  P.  Portal,  and  G. B.  Snyder.  1968. Renal xenograft 
prolongation by suppression of natural antibody. J. Surg.  Res. 8:211. 
8.  Snyder, G. B., E. Ballesteros,  R. M. Zarco, and B. S. Linn.  1966. Prolongation 
of  renal  xenografts  by  complement  suppression.  Surg.  Forum  Proc.  Forum 
Fundam. Surg. Probl. Clin. Congr. Amer. Coll. Surg. 17:478. 
9.  Jensen,  J.  A.  1967.  Anaphylatoxin  in  its  relation  to  the  complement  system. 
Science (Washington).  155:1122. 
10.  Jensen, J. A., R. Snyderman, and S. E. Mergenhagen. 1969. Chemotactic activity, 
a  property of guinea pig C%anaphylatoxin.  Third  International  Symposium 
on Cellular and Humoral Mechanisms of Anaphylaxis and Allergy. S. Karger 
AG, Basel, Switzerland. In press. 
1  I.  Jensen, J. A., and R. Stolfi.  1969. In vitro synthesis of C'4 by guinea pig liver. 
Fed. Proc. 28:497. 
12.  Ratnoff, O.  D., and I. H. Lepow.  1957.  Some properties of an esterase derived 
from preparations of the first component of complement. J. Exp. Med. 106:327. 
13.  Pensky, J., L. R. Levy, and I. H. Lepow.  1961. Partial purification of a  serum 
inhibitor of C'I esterase. J. Biol.  Chem. 236:1674. 
14.  Lepow,  I. H.,  and  M.  A. Leon.  1962.  Interaction of a  serum  inhibitor  of  C'I 
esterase with intermediate complexes of the immune hemolytic system. Immu- 
nology. 5:222, 5:235. 
15.  Tamura, N., and R. A. Nelson. 1967. Three naturally occurring inhibitors of com- 
plement in guinea pig and rabbit serum. J. Immunol. 99:582. 
16.  Lepow, I. H., G. B. Naff, and J. Pensky. 1965. Mechanism of activation of C'I 
and inhibition of C'I esterase.  Ciba Found. Syrup.  Complement.  74. 
17.  Opferkuch,  W.,  R.  Ringelmann,  and  P.  G.  Klein.  1968. Characterisation  of a JOERG A.  yENSE~  241 
C'4 inactivator and its generation from guinea pig euglobulin.  3". Immunol. 
101:815. 
18.  Haines, A. L., and I. H. Lepow. 1963. Studies  on human C'1 esterase II. J. In~ 
munol. 92.'468. 
19.  Haines, A. L., and I. H. Lepow. 1953. Studies on human C'1 esterase I. Y. Immu- 
hog. 92:455. 
20.  Nelson,  R. A.  1955. A  new  concept of immunosuppression in hypersensitivity 
reactions and transplantation immunity. Sum. OphthalmoL 11:498. 
21.  Maillard, J. L., and R. Zarco, 1958. Decomplementation par un facteur extrait 
du venin de cobra. Effet sur plusieurs r6actions immunes du cobaye et du rat. 
Ann. Inst. Pasteur  (Paris). 114:756. 
22.  Shin, H. S., H. Gewiirz, and R. Snyderman. 1969. Reaction of cobra venom factor 
with guinea pig complement and generation of an activity chemotactic for 
polymorphonuclear leukocytes. Proc. Soc. Exp. Biol. Med. In press. 